142 related articles for article (PubMed ID: 24261543)
1. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
[TBL] [Abstract][Full Text] [Related]
2. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
3. XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.
Zaretzki J; Matlock M; Swamidass SJ
J Chem Inf Model; 2013 Dec; 53(12):3373-83. PubMed ID: 24224933
[TBL] [Abstract][Full Text] [Related]
4. Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.
Raunio H; Juvonen RO; Poso A; Lahtela-Kakkonen M; Rahnasto-Rilla M
Drug Metab Lett; 2016; 10(1):56-64. PubMed ID: 26648056
[TBL] [Abstract][Full Text] [Related]
5. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity.
Bello M; Mendieta-Wejebe JE; Correa-Basurto J
Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636
[TBL] [Abstract][Full Text] [Related]
6. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
7. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations.
Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX
J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334
[TBL] [Abstract][Full Text] [Related]
8. Importance of hydrophobic parameters in identifying appropriate pose of CYP substrates in cytochromes.
Ramesh M; Bharatam PV
Eur J Med Chem; 2014 Jan; 71():15-23. PubMed ID: 24269512
[TBL] [Abstract][Full Text] [Related]
9. Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation.
Capoferri L; Verkade-Vreeker MC; Buitenhuis D; Commandeur JN; Pastor M; Vermeulen NP; Geerke DP
PLoS One; 2015; 10(11):e0142232. PubMed ID: 26551865
[TBL] [Abstract][Full Text] [Related]
10. Regioselectivity prediction of CYP1A2-mediated phase I metabolism.
Jung J; Kim ND; Kim SY; Choi I; Cho KH; Oh WS; Kim DN; No KT
J Chem Inf Model; 2008 May; 48(5):1074-80. PubMed ID: 18412330
[TBL] [Abstract][Full Text] [Related]
11. Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.
Kingsley LJ; Wilson GL; Essex ME; Lill MA
Pharm Res; 2015 Mar; 32(3):986-1001. PubMed ID: 25208877
[TBL] [Abstract][Full Text] [Related]
12. Understanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s.
Yang Y; Wong SE; Lightstone FC
PLoS One; 2014; 9(2):e87058. PubMed ID: 24498291
[TBL] [Abstract][Full Text] [Related]
13. Computational insights into the different catalytic activities of CYP2A13 and CYP2A6 on NNK.
Xu Y; Shen Z; Shen J; Liu G; Li W; Tang Y
J Mol Graph Model; 2011 Sep; 30():1-9. PubMed ID: 21680215
[TBL] [Abstract][Full Text] [Related]
14. Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures.
Danielson ML; Desai PV; Mohutsky MA; Wrighton SA; Lill MA
Eur J Med Chem; 2011 Sep; 46(9):3953-63. PubMed ID: 21703735
[TBL] [Abstract][Full Text] [Related]
15. Ligand aligning method for molecular docking: alignment of property-weighted vectors.
Joung JY; Nam KY; Cho KH; No KT
J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323
[TBL] [Abstract][Full Text] [Related]
16. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
[TBL] [Abstract][Full Text] [Related]
17. Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculations.
Vasanthanathan P; Olsen L; Jørgensen FS; Vermeulen NP; Oostenbrink C
Drug Metab Dispos; 2010 Aug; 38(8):1347-54. PubMed ID: 20413725
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD).
Lokwani DK; Sarkate AP; Karnik KS; Nikalje APG; Seijas JA
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244772
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands.
Vasanthanathan P; Hritz J; Taboureau O; Olsen L; Jørgensen FS; Vermeulen NP; Oostenbrink C
J Chem Inf Model; 2009 Jan; 49(1):43-52. PubMed ID: 19099399
[TBL] [Abstract][Full Text] [Related]
20. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]